Clinical Trial Update: A 6-month, Randomized, Double-blind, Placebo Controlled Study Evaluating the Efficacy and Safety of USPlus DERM to Promote Hair Growth in Men and Women With Self-perceived Thinning Hair. [NA]

View source ↗

Summary

A 6-month, randomized, double-blind, placebo-controlled trial evaluating USPlus DERM for hair growth in men and women with self-perceived thinning hair. The stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hair Loss

Drugs mentioned

• USPlus DERM

Snippet

Sponsor: Ablon Skin Institute Research Center | Conditions: Thinning Hair | NA | Status: ACTIVE_NOT_RECRUITING